[1] |
高永强, 施鹏伟, 师文楷, 等. 长链非编码RNA HCG22在口腔鳞状细胞癌中的表达及作用机制研究[J]. 华西口腔医学杂志, 2021, 39(6): 658-666.
|
|
Gao YQ, Shi PW, Shi WK, et al. Expression and mechanism of long non-coding RNA HCG22 in oral squamous cell carcinoma[J]. West China J Stomatol, 2021, 39(6): 658-666.
|
[2] |
Arslan Bozdag L, Inan S, Elif Gultekin S. Microsatellite instability and loss of heterozygosity as prognostic markers in oral squamous cell carcinoma: molecular me-chanisms, detection techniques, and therapeutic strategies[J]. Genes Chromosomes Cancer, 2024, 63(10): e70002.
|
[3] |
Chaudhary AA, Fareed M, Khan SU, et al. Exploring the therapeutic potential of lipid-based nanoparticles in the management of oral squamous cell carcinoma[J]. Explor Target Antitumor Ther, 2024, 5(6): 1223-1246.
|
[4] |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263.
|
[5] |
Zhang JY, Ni ZH, Zhang Y, et al. DAZAP1 phase separation regulates mitochondrial metabolism to facilitate invasion and metastasis of oral squamous cell carcinoma[J]. Cancer Res, 2024, 84(22): 3818-3833.
|
[6] |
丁啸, 陈嘉雯, 曲鹏宇, 等. miR-362-3p调控垂体肿瘤转化基因1抑制口腔鳞状细胞癌侵袭及增殖的研究[J]. 华西口腔医学杂志, 2024, 42(1): 46-55.
|
|
Ding X, Chen JW, Qu PY, et al. miR-362-3p inhibited the invasion and metastasis of oral squamous cell carcinoma cells by targeting the regulation of pituitary tumor-transforming gene 1[J]. West China J Stomatol, 2024, 42(1): 46-55.
|
[7] |
李欣, 裴辰玮, 金建秋, 等. 光动力疗法在口腔鳞状细胞癌中的研究进展[J]. 中国医学前沿杂志(电子版), 2024, 16(10): 85-91.
|
|
Li X, Pei CW, Jin JQ, et al. Research advances in action mechanisms of photodynamic therapy and photosensiti-zer[J]. Chin J Med Front (Electron Ed), 2024, 16(10): 85-91.
|
[8] |
Alessandrini F, Pezzè L, Ciribilli Y. LAMPs: shedding light on cancer biology[J]. Semin Oncol, 2017, 44(4): 239-253.
|
[9] |
Umeda S, Kanda M, Shimizu D, et al. Lysosomal-asso-ciated membrane protein family member 5 promotes the metastatic potential of gastric cancer cells[J]. Gastric Cancer, 2022, 25(3): 558-572.
|
[10] |
杨书瀚, 裴筱涵, 祁义军. LAMP5在结直肠癌发生发展和预后中的作用[J]. 安徽医科大学学报, 2022, 57(8): 1338-1344.
|
|
Yang SH, Pei XH, Qi YJ. Expression of LAMP5 in co-lorectal cancer and its significance in occurrence, deve-lopment and prognosis[J]. Acta Univ Med Anhui, 2022, 57(8): 1338-1344.
|
[11] |
Gracia-Maldonado G, Clark J, Burwinkel M, et al. LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for mixed lineage leukemia-rearranged acute leukemia[J]. Haematologica, 2022, 107(4): 803-815.
|
[12] |
Ždralević M, Radović A, Raonić J, et al. Advances in microRNAs as emerging biomarkers for colorectal cancer early detection and diagnosis[J]. Int J Mol Sci, 2024, 25(20): 11060.
|
[13] |
陈卉, 高永泽, 党云, 等. miRNA在宫颈恶性肿瘤中的意义及其研究进展[J]. 医学理论与实践, 2024, 37(11): 1839-1842.
|
|
Chen H, Gao YZ, Dang Y, et al. The significance of miRNA in cervical malignancies and its research progress[J]. J Med Theory Pract, 2024, 37(11): 1839-1842.
|
[14] |
任亚丽, 吴伟, 邵建华, 等. miR-302a-3p在食管鳞癌中的表达及临床意义[J]. 扬州大学学报 (农业与生命科学版), 2022, 43(6): 87-93.
|
|
Ren YL, Wu W, Shao JH, et al. Expression and clinical significance of miR-302a-3p in esophageal squamous carcinoma[J]. J Yangzhou Univ (Agric Life Sci Ed), 2022, 43(6): 87-93.
|
[15] |
Chang X, Lin YY, Bai LN, et al. miR-302a-3p suppres-ses melanoma cell progression via targeting METTL3[J]. J Chemother, 2022, 34(1): 55-66.
|
[16] |
Li J, Li YZ, Sun XD, et al. Silencing lncRNA-DARS-AS1 suppresses nonsmall cell lung cancer progression by stimulating miR-302a-3p to inhibit ACAT1 expression[J]. Mol Carcinog, 2024, 63(4): 757-771.
|
[17] |
Ghanem AS, Memon HA, Nagy AC. Evolving trends in oral cancer burden in Europe: a systematic review[J]. Front Oncol, 2024, 14: 1444326.
|
[18] |
Tan YH, Wang ZH, Xu MT, et al. Oral squamous cell carcinomas: state of the field and emerging directions[J]. Int J Oral Sci, 2023, 15(1): 44.
|
[19] |
Struckmeier AK, Eichhorn P, Agaimy A, et al. Comparison of the 7th and revised 8th UICC editions (2020) for oral squamous cell carcinoma: how does the reclassifi-cation impact staging and survival[J]. Virchows Arch, 2024, 484(6): 901-913.
|
[20] |
Ganesh K, Massagué J. Targeting metastatic cancer[J]. Nat Med, 2021, 27(1): 34-44.
|
[21] |
Chen Y, Ma T. LAMP5 may promote MM progres-sion by activating p38[J]. Pathol Oncol Res, 2023, 29: 1611083.
|
[22] |
Ye Y, Song YN, Zhuang JH, et al. microRNA-302a-3p suppresses hepatocellular carcinoma progression by inhibiting proliferation and invasion[J]. Onco Targets Ther, 2018, 11: 8175-8184.
|
[23] |
Wei D, Ke YQ, Duan P, et al. microRNA-302a-3p indu-ces ferroptosis of non-small cell lung cancer cells via targeting ferroportin[J]. Free Radic Res, 2021, 55(7): 821-830.
|